Glucocorticoid resistance was previously associated with a proliferative phenotype involving upregulation of glycolysis, cholesterol biosynthesis, and activation of PI3K/Akt/mTOR and Myc signaling pathways [39, 56]. The gene discussed is MTOR; the disease is glucocorticoid resistance.